Is It Time to Move Beyond Standardized Treatment Pathways for HCC? – Asia-Pacific Gastroenterology Cancer Summit
Asia-Pacific Gastroenterology Cancer Summit shared a post on LinkedIn:
“Is it time to move beyond standardized treatment pathways for HCC?
Join us at the Lunch Satellite Symposium at APGCS 2025 for an in-depth session: Beyond the Algorithm: Personalizing Systemic Therapy in Intermediate–Advanced HCC
1st August 2025 | 12:15 – 13:00 HRS (SGT)
This expert-led symposium will explore real-world strategies for tailoring systemic therapies in hepatocellular carcinoma — focusing on patient-centric decision-making, sequencing of treatment, and integrating biomarkers and clinical context to optimize outcomes.
Whether you’re a hepatologist, medical oncologist, or part of a multidisciplinary liver team, this session offers crucial insights into elevating your clinical approach in managing intermediate-advanced HCC.
Reserve your seat now.”
More posts featuring Asia-Pacific Gastroenterology Cancer Summit.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023